DeSantis poised to sign legislation banning psychedelic mushroom spores in Florida
Gov. Ron DeSantis said last week that he will soon sign legislation that, among its provisions, would ban trafficking in psychedelic mushroom spores.
That measure is part of an omnibus 'Florida Farm Bill' (SB 700) sponsored by Central Florida Republican Keith Truenow that is best known for including a ban on certain additives like fluoride in the drinking water supply.
Psilocybin mushrooms are illegal in the United States for possession and sale, because psilocybin is considered a controlled substance. Psilocybin spores, the small reproduction units that get dispersed by fungi, are legal, however, because they don't contain psilocybin, according to the U.S. Drug Enforcement Administration.
As the bill's House analysis says, 'Certain mushroom spores and mycelium, which is a type of fungi, can be propagated and grown into mushrooms that have psilocybin properties. But the spores do not contain any psilocybin properties themselves and therefore could be considered legal under current law.'
A violation of the new ban would be a first-degree misdemeanor, punishable by up to a year in jail and a fine of $1,000.
The decision is disappointing to those who believe the use of psychedelic mushrooms can help people experiencing treatment-resistant depression. The Food and Drug Administration (FDA) in 2018 bestowed a 'breakthrough-therapy' designation to a British life sciences company for its psilocybin therapy for treatment-resistant depression. The FDA designates a drug as such if preliminary clinical evidence shows it may demonstrate substantial improvement over available therapy.
Small clinical trials have shown that individual doses of psilocybin, given in a therapeutic setting, can make major changes in people suffering from treatment-resistant major depressive disorder, CNN reported in 2022.
That's what led former Miami Beach Democrat Mike Grieco to introduce legislation back when he served in the Florida House of Representatives a few years ago to direct the Florida Department of Health and the Board of Medicine to study the therapeutic efficacy of alternative therapies like psilocybin. That legislation didn't advance.
'Despite my legislation from a few years ago not gaining traction, we have seen throughout the country and internationally expanded acceptance of psilocybin and other psychedelics in the mental health and the therapeutic space,' Grieco told the Phoenix.
'It's a shame that Florida has not taken advantage of the psilocybin redesignation by the FDA that allows for research and clinical studies. I would love to see our state make these therapies available to our veterans and first responder organizations.'
Grieco's bill called for the Department of Health, in collaboration with the Board of Medicine, to evaluate the therapeutic efficacy of alternative therapies, including the use of MDMA (a/k/a ecstasy), psilocybin, and ketamine in treating mental and other medical conditions, including depression, anxiety, PTSD, bipolar disorder, chronic pain, and migraines.
A significant setback for the movement to bring psychedelics into the mainstream of mental health care took place last summer after the FDA opted not to approve MDMA-assisted therapy for PTSD. Instead, the agency asked Lykos Therapeutics to further study the safety and efficacy of the treatment, according to CNN.
As the House bill analysis says, 'psilocybin, also known as 'magic mushrooms,' are naturally occurring and consumed for their hallucinogenic effects.'
Under Florida law, psilocybin and psilocyn are classified as Schedule I substances. Possession of psilocybin in Florida is a third-degree felony.
Those who work in the psychedelic space think it's a poor move by the Legislature.
'Florida is trying to outlaw the literal roots of the psychedelic renaissance — the mycelium that connects hope, healing, and nature itself,' said Peter Sessa, a lead organizer for Cannadelic Miami, a cannabis and psychadelics expo that will take place later this month at the Miami Airport Convention Center. 'This bill doesn't just ban mushroom spores – it bans connection, curiosity, and the future of mental health.'
Carlos Hermida owns Chillum Mushrooms and Hemp Dispensary, which has locations in Tampa and St. Petersburg.
'I don't think lawmakers should be making the potentiality of something illegal,' he contends. 'Are we going to start making it illegal because we think someone could grow up to rob a liquor store or something like that?'
Hermida adds that Mycelium is a fungus that grows in the ground. 'This particular fungus grows in manure. Is manure now illegal in Florida? Is rotting manure now illegal. Is that what's going on?'
There was no public debate on the provision during discussion of the farm bill in the Legislature. It consists of just eight lines in the 111-page bill.
In recent years, Oregon and Colorado passed legislation decriminalizing psilocybin and legalizing its supervised use. Cities like Berkeley, Seattle, and Detroit have also decriminalized the psychedelic mushrooms.
Calls to U.S. poison centers involving psilocybin among adolescents and young adults rose sharply after several U.S. cities and states began decriminalizing the substance, University of Virginia School of Medicine researchers found in a 2024 study.
Ellen Snelling of the Hillsborough County Anti-Drug Alliance said that she wasn't that familiar with the measure banning psilocybin spores, but had a bigger concern about alternatives to psilocybin.
'A variety of psychedelic mushroom products are sold in smoke shops in Florida. An emergency room doctor told me he's seeing more people coming in after using mushrooms,' she said.
Once the measure is signed by DeSantis, Florida will join states like Georgia and Idaho in tightening regulations on psychedelic mushroom spores.
SUPPORT: YOU MAKE OUR WORK POSSIBLE
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
FluMist, a vaccine nasal spray, is now available for use at home
Those looking to protect themselves against the flu this season now have an at-home option. FluMist, the only nasal spray flu vaccine approved by the Food and Drug Administration, is now available for purchase for self-administration. AstraZenca's FluMist was approved in 2003 to be given by health care providers. Last year, the FDA broadened the approval of the nasal spray to make it the first self-administered option. An at-home delivery service, called FluMist Home, will be available in 34 states this flu season. Through FluMist Home, customers can get the same FluMist nasal spray — shipped to their homes — that patients can receive at a doctor's office or pharmacy. How much does FluMist cost? According to the online ordering platform, FluMist is free under most commercial insurance. There is, however, a fee of $8.99 for shipping and processing. To order, customers have to give some basic personal information, medical details, insurance information and a payment method. Who can use FluMist at home? FluMist is approved for at-home use for those ages 2 to 49, but a caregiver should administer FluMist to individuals 2 through 17, according to the website. The website includes instructions on how to administer the spray to yourself and family members. FluMist should not be used in people with "a severe allergy to its components, eggs or other flu vaccines," according to the product's website, which offers a full list of patient and safety information. What states is FluMist Home available in? According to a news release, FluMist Home will be available in the following states for the 2025-2026 flu season: AlabamaArizonaCaliforniaColoradoConnecticutFloridaGeorgiaIowaIdahoIllinoisMassachusettsMarylandMaineMichiganMontanaNorth CarolinaNorth DakotaNebraskaNew HampshireNew JerseyNevadaOhioOregonPennsylvaniaSouth CarolinaSouth DakotaTennesseeTexasUtahVirginiaVermontWashingtonWisconsinWyoming "There are a number of states where FluMist Home is unavailable due to local pharmacy laws," the release notes. "Our aim is to have this service available in all 48 contiguous states in future seasons." Passenger arrested after allegedly causing disturbance midair and forcing flight to divert When could Tropical Storm Erin become a hurricane? Urban garden helps combat food insecurity in Miami Solve the daily Crossword


The Hill
28 minutes ago
- The Hill
Rove warns Trump against overpromising on economy
Republican strategist Karl Rove warned President Trump about making too many promises to the American people about the quality of the economy, predicting failure to deliver could cost Republicans in the midterm elections. 'On economics, Team Trump is making the same mistake as the last administration,' Rove wrote in a recent op-ed for the Wall Street Journal. 'President Biden and big-name Democrats went across America proclaiming 'Bidenomics is working.' People felt the opposite.' The danger for Trump, the cable news pundit argued, is 'he's addicted to superlatives and self-congratulations and prone to declaring premature success.' 'While Republicans generally agree with the president's depiction of things, independents don't,' Rove, who previously served as a top aide to former President George W. Bush, continued. 'They are deeply concerned about tariffs, debt and prices.' He also wrote that Trump and his allies 'would be smarter to underpromise and overdeliver, especially since righting the economy will take time.' 'It's self-destructive for Republicans to make over-the-top claims,' the pundit wrote. 'How voters feel about their own circumstances will hugely influence next year's outcome. Seeming out of touch could make the midterms even harder.' The analysis comes as the president seeks to reassure the public about the economy following the latest dismal jobs report and uncertainty around his trade agenda following the latest rollout of tariffs on foreign trading partners.


Axios
28 minutes ago
- Axios
Cornyn shows signs of life in Texas Senate poll
Sen. John Cornyn has finally climbed within the margin of error against Texas Attorney General Ken Paxton in new, independent polling of Texas GOP primary voters. Why it matters: It's the first poll since outside groups spent millions of dollars on pro-Cornyn advertising, and since news broke of Paxton's divorce. Cornyn's primary chances have otherwise looked bleak, despite Senate GOP leaders warning the White House and major donors that a Paxton nomination could risk the seat. Zoom in: The Emerson poll released Friday has Cornyn with 30% of Texas GOP primary voters, and Paxton with 29%. The margin of error is +/- 4.4%. The same poll showed 37% of voters still undecided. It's a major improvement for Cornyn, after polls earlier this summer showed him down by double digits to Paxton. The Emerson poll has Cornyn beating Democrat Colin Allred in a hypothetical match up by seven percentage points, with Paxton winning over Allred by five percentage points. Zoom out: Groups affiliated with the Senate Leadership Fund, a super PAC that's linked to Senate Republican leadership, have spent more than $4 million over the past month to boost Cornyn with Texas voters, according to AdImpact. Another pro-Cornyn super PAC spent an additional $3+ million over the same time frame. SLF has been warning donors that it could cost tens of millions of dollars to help Cornyn win the primary — though they add it could save them from having to spend hundreds of millions to help Paxton keep the seat from Democrats, as Punchbowl News first reported. Methodology: The Emerson poll was conducted August 11-12 with a sample of 1,000 Texas registered voters. The GOP subsample was 491 and the subsample credibility interval (similar to a margin of error) was +/-4.4%.